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Overview of original SPHERE study 
 • The SPHERE Study was the largest ever non-
pharmaceutical trial in general practice on the island of 
Ireland. The study began in 2003 and ended in 2007. 
 
Aims: 
• To design, implement and test an intervention to 
improve the process of care and clinical outcomes for 
patients with established coronary heart disease 
(CHD).  
• To reduce rates of illness and premature death for 
patients with CHD and to improve the care they receive 
in general practice. 
 
SPHERE Study Rationale 
 
• People with CHD had been highlighted both 
nationally and internationally as a priority group 
for prevention efforts  
 
• General Practice is the ideal setting for targeting 
these patients 
 
• Previous research showed there was 
considerable room for improvement 
 
 
 
SPHERE STUDY SUMMARY 
• 903 patients with heart disease (315 in Northern 
Ireland) 
• 48 general practices in the East, North and West of 
Ireland (16 per region) 
• 24 practices were randomly allocated to receive the 
intervention for 18 months; 24 continued to provide 
usual care  
• Patient risk factor and health status data were 
collected at baseline and 18 months  
                Questionnaires 
              Medical records 
 
 
Q 
SPHERE Study Intervention 
  Designed in consultation with patients and practitioners: 
 
 
 
 
 
 
 
 
 
 
 Practitioners attended two 90-minute training sessions: 
o Facilitating lifestyle behaviour change 
o Optimal medication prescribing for secondary prevention 
 
 Patients visited the practice for review every 4 months.  
o Tailored patient care: SPHERE booklet – personal action plan 
o Targets and goals for optimal secondary prevention reviewed 
patient-centred care  
brief motivational interviewing 
best practice in prescribing 
SPHERE Study               
 Fewer patients were admitted to hospital over the 18 months in 
the intervention group : 26% v 34% 
 
 After 18 months there were no significant differences in risk factor control:  
 
• Systolic BP >140 mmHg:         intervention 27%; control 33% 
• Diastolic BP >90 mmHg:          intervention   9%; control 10% 
• Total cholesterol >5mmol/l:   intervention 15%; control 16% 
 
 No other clinical benefits shown - possible ‘ceiling effect‘ related to improved   
management of CHD 
 
Murphy, Cupples, Smith et al. BMJ 2009;339:b4220  
 
 
 
Follow-up to the SPHERE study 
 
 
A six-year follow-up to the 
SPHERE study commenced in 
January 2012  
 
 
               The aim -     
to trace the 903 original participants and explore if the 
positive changes in admissions are still happening, in 
the longer term, after six years. 
Method  
• Contacted practices  
• Employed face to face visits & telephone calls 
• All practices agreed to take part  
 
• Practices were facilitated to trace original patients 
• Research nurses worked with practitioners 
• Patients were posted study information, and form to 
indicate consent 
 Patients 
Short postal questionnaire 
  
Research Nurses 
Data collection from records  
Questionnaire & patient record 
data entered into SPSS 
 
 
 
Post Consent 
Tracing patients 
• In NI 16 patients had left the practice 
• With ethics committee approval, contact was made 
with BSO ( Business Service Organisation) 
 
Two categories: 
• Patients who had moved and were deceased - BSO 
provided cause of death 
• Patients who had moved and were alive - BSO posted 
study info and invitation to join the follow up study 
Contacting patients who had left the 
practice 
No ID Info from practices BSO Outcome 
1 3403 left practice Contacted via BSO  No reply 
2 3419 left practice Contacted via BSO  Pt consented & completed Q 
3 3423 left practice Contacted via BSO No reply 
4 3436 left practice info via BSO Pt died Heart Failure* 
5 3516 left practice Contacted via BSO Pt consented & completed Q 
6 3521 left practice Contacted via BSO No reply 
7 3706 left practice Contacted via BSO No reply 
8 4019 left practice Contacted via BSO Pt consented & completed Q 
9 4134 left practice Contacted via BSO Pt consented & completed Q 
10 4320 left practice Contacted via BSO No reply 
11 4513 left practice Contacted via BSO Pt consented & completed Q 
12 4631 left practice  info via BSO  Pt died Myocardial Infarction* 
13 4635 left practice Contacted via BSO No reply 
14 4706 left practice Contacted via BSO No reply 
15 4719 Patient moved to Scotland Unable to contact 
16 4720 left practice info via BSO Pt died Myocardial Infarction * 
Example 
Northern Ireland 
19 
15 
5 
4 
3 
Cardiovascular Cancer Cerebrovascular Other Respiratory
Cause of death (n=46) 
Of the original 903 patients 886 (98%) were traced 
 
Patients Deceased:  138 (15.3%)  
No Response:            68   (8.6%)  
Declined:                    31   (3.9%) [equally divided across arms] 
 
Data were collected from practice medical records :  
Intervention Group: 339 (76%) 
Control Group: 357 (78%) 
 
Questionnaire return rate: (92%)  
 
Similar methods were employed in the Republic of Ireland  

• No significant differences between 
intervention and control practices in hospital 
admissions   
• No differences in mortality 
 
• No differences in proportions of patients 
above target control for blood pressure or 
total cholesterol.  
 
Percentage of participants outside secondary 
prevention risk marker guidelines at baseline 
and 6 years  
   SPHERE SPHERE Follow UP 
Variable Intervention Control Intervention Control 
          
Systolic BP 
>140 mm Hg 
 
34.1  
 
33.8  31.5  24.3 
Diastolic BP  
>90 mm Hg 
 
13.3  
 
11.4  3.8  3.3  
Total cholesterol 
>5.0 mmol/l 
 
21.7  
 
22.0  13.9  13.6  
  
Overall risk factor control was much improved from 
baseline in both groups 
 
• MORTALITY 
• BLOOD PRESSURE             no difference 
• CHOLESTEROL 
 
 
Conclusions 
 
• Long term follow-up of interventions in primary care           
                       - is possible and 
                       - is needed to assess sustainability of effect 
 
• Policy makers should consider  
                 - regular review of previously effective programmes       
                 - and a ‘turn on, turn off’ strategy of support 
  
• Improvements are on-going, in the quality of care   
                                                               provision in primary care 
 
 
• Funder: Health Research Board, Ireland  
• Participating practices 
• The SPHERE patients 
• The Research Nurses 
 
Northern Ireland (Population 1.8 million) 
• Publicly funded (NHS) 
• No charges for access to primary care or hospital care 
• People are registered for primary care in a specified general practice 
• Practices receive financial incentives for using disease registers and 
monitoring quality of care 
• Prescriptions are free 
 
Republic of Ireland (Population 4.58 million) 
• Mixed public and private funding 
• Primary health care is free via the General Medical Services scheme (GMS) to 
those judged less able to pay or aged > 70  
• Registration with a practice required only if patient is in the GMS scheme 
• Subsidised prescriptions are available (€2.50 per item) within GMS scheme; 
others pay full cost of medicines, to monthly limit (£84/€90 per family) 
 
 
 
 
 
 
 
 
return 
 
• It is important to interpret research in the 
context of current evidence 
 
 
return 
